ARS Wealth Advisors’s Biogen BIIB Stock Holding History

ARS Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$481K	Buy	1,388 +54	+4%	+$16.4K	0.09%	84
2021 Q1	$373K	Buy	+1,334	New	+$360K	0.08%	88
2019 Q1	–	Sell	-760	Closed	-$229K	–	108
2018 Q4	$229K	Buy	760 +85	+13%	+$27.1K	0.08%	94
2018 Q3	$238K	Sell	675 -90	-12%	-$31K	0.08%	105
2018 Q2	$222K	Buy	765 +33	+5%	+$9.28K	0.08%	105
2018 Q1	$200K	Sell	732 -257	-26%	-$79.8K	0.07%	113
2017 Q4	$315K	Buy	989 +131	+15%	+$42K	0.12%	90
2017 Q3	$269K	Buy	+858	New	+$254K	0.1%	102

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

ARS Wealth Advisors's BIIB Position: Q2 2021 in Review

ARS Wealth Advisors increased its Biogen (BIIB) stake by 4% in Q2 2021, buying an estimated $16.4K and bringing the position to 1,388 shares worth $481K. The position accounts for 0.09% of the portfolio, ranked #84.

ARS Wealth Advisors first reported a position in BIIB in Q3 2017 and has held it in 8 quarters since. 1,105 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

ARS Wealth Advisors held 1,388 shares of Biogen worth $481K as of Q2 2021.
ARS Wealth Advisors bought 54 Biogen shares in Q2 2021, an estimated $16.4K.
Biogen made up 0.09% of ARS Wealth Advisors's portfolio in Q2 2021, its #84 holding.
ARS Wealth Advisors first reported a position in Biogen in Q3 2017 and has held it in 8 quarters since.
1,105 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on ARS Wealth Advisors's 13F filing for Q2 2021, filed 15 Jul 2021.